Tetrahydrocannabivarin is a homologue of tetrahydrocannabinol having a propyl side chain instead of pentyl, making it non-psychoactive in lower doses. From Wikipedia
It reveals up to twenty times more genomic variation than in humans, highlighting male-linked genes that offer new targets for enhancing cannabinoid production.
